February 10, 2025 - 22:06

The board of Microchip Technology Incorporated has announced that it will pay a dividend of $0.455 per share. This payment is scheduled for distribution on the 7th of next month, marking a significant return for shareholders. The company has consistently prioritized shareholder value, and this dividend reflects its strong financial position and commitment to delivering returns.
Investors will receive the dividend if they hold shares before the ex-dividend date, which is typically set a few days prior to the payment date. Microchip Technology has established a reputation for stability and growth in the semiconductor industry, and this dividend announcement underscores its ongoing success and profitability.
As the company continues to innovate and expand its product offerings, shareholders can look forward to this financial reward as a testament to Microchip's robust performance. This move is expected to enhance investor confidence and attract new stakeholders interested in the company's future growth potential.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...